StockData
Q32 Bio Inc. logo

Q32 Bio Inc. (QTTB) stock

QTTBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/30
$8.63+0.34 (+4.10%)

Close on Nov 17, 2026Market cap $256.91MP/E –Yield –

Q32 Bio operating margin

Operating margin is operating income as a percentage of revenue.

Q32 Bio's operating margin for the twelve months ending Jun 30, 2024 was -3570.1%. For fiscal 2025 it was 31.5%, against -4154.6% the year before. The highest annual figure on record is 31.5% in fiscal 2025.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202531.5%+4186.1
FY2022Dec 31, 2022-4154.6%−3872.2
FY2021Dec 31, 2021-282.4%+4538.5
FY2020Dec 31, 2020-4821.0%+1778.2
FY2019Dec 31, 2019-6599.2%−5473.2
FY2018Dec 31, 2018-1126.0%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2023Sep 30, 2023-419.5%+3678.0
Q2 FY2023Jun 30, 2023-227.0%+3302.6
Q1 FY2023Mar 31, 2023-250.2%+4440.3
Q4 FY2022Dec 31, 2022-4301.0%−108.4
Q3 FY2022Sep 30, 2022-4097.5%−2269.2
Q2 FY2022Jun 30, 2022-3529.6%−2132.6
Q1 FY2022Mar 31, 2022-4690.5%−4686.7
Q4 FY2021Dec 31, 2021-4192.6%−1151.6
Q3 FY2021Sep 30, 2021-1828.3%+3158.1
Q2 FY2021Jun 30, 2021-1397.0%+4898.8
Q1 FY2021Mar 31, 2021-3.8%+6202.3
Q4 FY2020Dec 31, 2020-3041.0%+1498.8
Q3 FY2020Sep 30, 2020-4986.4%+2108.4
Q2 FY2020Jun 30, 2020-6295.8%+840.2
Q1 FY2020Mar 31, 2020-6206.1%+3098.7
Q4 FY2019Dec 31, 2019-4539.8%−2853.2
Q3 FY2019Sep 30, 2019-7094.8%−6118.8
Q2 FY2019Jun 30, 2019-7136.0%−6173.8
Q1 FY2019Mar 31, 2019-9304.8%−8357.4
Q4 FY2018Dec 31, 2018-1686.6%–
Q3 FY2018Sep 30, 2018-976.0%–
Q2 FY2018Jun 30, 2018-962.2%–
Q1 FY2018Mar 31, 2018-947.4%–

More Q32 Bio figures

See a number that looks wrong?